The Mesothelioma Center News - Page 2
Medicare Now Covers CAR T-Cell Therapy for Approved Cancers
- by Matt Mauney
- Treatment & Doctors
- Sep 19, 2019
A promising and expensive type of immunotherapy, called CAR T-cell therapy, is now covered by Medicare. This news may affect mesothelioma patients in the future. Chimeric antigen…
Read More
Mesothelioma Cells Slowed by Grape-Seed Extracts
- by Tim Povtak
- Research & Clinical Trials
- Sep 12, 2019
Extracts from two Italian grape varieties showed distinct anti-cancer activity in three different mesothelioma cell lines, according to a recent multicenter study in Naples, Italy. The in-vitro findings strongly suggest…
Read More
Asbestos in Makeup Leads to Recall of City Color Products
- by Matt Mauney
- Asbestos Exposure & Bans
- Sep 9, 2019
Beauty Plus Global Inc., the cosmetics and packaging manufacturer behind City Color and Max Mell, has issued a voluntary recall of four City Color makeup products that tested positive for…
Read More
Mesothelioma Clinical Trial Targets Latest Gene Therapy
- by Tim Povtak
- Research & Clinical Trials
- Sep 4, 2019
Pioneering pulmonologists Dr. Steven Albelda and Dr. Daniel Sterman have worked for more than 20 years on developing gene therapy to effectively combat pleural mesothelioma cancer. The payoff may…
Read More
MD Anderson Remains Top-Ranked Cancer Center
- by Tim Povtak
- Treatment & Doctors
- Aug 28, 2019
U.S. News & World Report named University of Texas MD Anderson Cancer Center in Houston as the No. 1 Adult Cancer Hospital in America for the fifth consecutive year.
Read More
Mesothelioma Study Explores New Treatment When Chemotherapy Fails
- by Tim Povtak
- Research & Clinical Trials
- Aug 26, 2019
A clinical trial is exploring whether a novel immunotherapy/antiangiogenic combination can serve as an effective second-line treatment for pleural mesothelioma. Early indications of the four-center, phase II clinical trial…
Read More
White House Asbestos Risk Forces Top Staff Relocation
- by Matt Mauney
- Asbestos Exposure & Bans
- Aug 22, 2019
The offices of some of President Donald Trump’s top aides, including his daughter Ivanka Trump and senior counselor Kellyanne Conway, have been temporarily relocated as the White House undergoes…
Read More
Clinical Trial Offering Personalized Immunotherapy for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Aug 14, 2019
Patients with mesothelioma are now eligible for a multicancer clinical trial studying the effectiveness of personalized immunotherapy at the University of California, San Diego Medical Center. The phase I…
Read More
Australian Study Shows Treatment Advances for Peritoneal Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Aug 12, 2019
Patients with peritoneal mesothelioma undergoing a second cytoreductive surgery had a median survival of 92 months, according to a recent study at St. George Hospital and the University of…
Read More
Baylor Opens New Immunotherapy Clinical Trial for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Aug 7, 2019
The Baylor College of Medicine in Houston has opened its latest clinical trial for mesothelioma patients to study the effectiveness of a novel immunotherapy combination. The nonsurgical, single-center study…
Read More
